Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,526) Arrow Down
Filter Results: (1,526) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,526)
    • People  (2)
    • News  (424)
    • Research  (829)
    • Events  (3)
    • Multimedia  (32)
  • Faculty Publications  (461)

Show Results For

  • All HBS Web  (1,526)
    • People  (2)
    • News  (424)
    • Research  (829)
    • Events  (3)
    • Multimedia  (32)
  • Faculty Publications  (461)
← Page 29 of 1,526 Results →

    Clayton S. Rose

    Clayton Rose is Baker Foundation Professor of Management Practice and teaches the course Accountability in the Advanced Management Program. His case writing is focused on the how leaders consider the... View Details

    Keywords: financial services
    • 02 Aug 2011
    • First Look

    First Look: August 2

    cause the accident. It then discusses the response to this spill by BP and the government. This helps provide some context for the decision by the Obama administration to request $20 billion for a fund from... View Details
    Keywords: Sean Silverthorne
    • Program

    Owner/President Management

    designed to foster collaborative learning and accelerate personal growth. Review Our Campus Health & Safety Protocols Alumni Status Upon completing the Owner/President Management program, you will become a... View Details
    • Program

    Leading in the Digital Era

    and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We admit candidates to specific sessions on a rolling,... View Details
    • 2023
    • Article

    Moral Escalation: Contested Category Emergence and Its Consequences in the Toy Industry

    By: Ryann Noe
    Preexisting research has outlined the cognitive, competitive, and economic barriers to market category emergence. Yet scholars have paid scant attention to the processes and consequences of moral resistance to nascent categories. Through a longitudinal, qualitative... View Details
    Keywords: Moral Sensibility; Market Entry and Exit; Product Positioning; Technology Industry; Consumer Products Industry
    Citation
    Register to Read
    Related
    Noe, Ryann. "Moral Escalation: Contested Category Emergence and Its Consequences in the Toy Industry." Academy of Management Proceedings (2023).
    • Spring 2014
    • Article

    Attracting Long-Term Investors Through Integrated Thinking and Reporting: A Clinical Study of a Biopharmaceutical Company

    By: Andrew Knauer and George Serafeim
    Faced with a large percentage of investors that chase short-term returns, companies could benefit by attracting investors with longer-term horizons and incentives that are more consistent with the long-term strategy of the company. The managers of most companies take... View Details
    Keywords: Investing; Asset Management; Long-term Investing; Short-termism; Sustainability; Integrated Reporting; Leadership & Corporate Accountability; Pharmaceuticals; Leadership; Integrated Corporate Reporting; Investment; Business and Stakeholder Relations; Corporate Finance; Biotechnology Industry; Pharmaceutical Industry
    Citation
    Find at Harvard
    Purchase
    Related
    Knauer, Andrew, and George Serafeim. "Attracting Long-Term Investors Through Integrated Thinking and Reporting: A Clinical Study of a Biopharmaceutical Company." Journal of Applied Corporate Finance 26, no. 2 (Spring 2014): 57–64.
    • Web

    Frequently Asked Questions

    Need Help? Find Answers and Support Here Curious about what to expect when coming to campus? Please visit our health & safety protocols page. For the latest coronavirus... View Details
    • 2022
    • Working Paper

    The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives

    By: Ariel Dora Stern
    For those who follow health and technology news, it is difficult to go more than a few days without reading about a compelling new application of Artificial Intelligence (AI) to health care. AI has myriad applications in medicine and its adjacent industries, with... View Details
    Keywords: AI and Machine Learning; Health Care and Treatment; Governing Rules, Regulations, and Reforms; Technological Innovation; Medical Devices and Supplies Industry
    Citation
    Find at Harvard
    Purchase
    Related
    Stern, Ariel Dora. "The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives." NBER Working Paper Series, No. 30639, December 2022.
    • 2007
    • Article

    Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation

    By: Arthur A. Daemmrich
    In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side effects after marketing, the safety of pharmaceuticals has come to the forefront of American public policy. Press attention, congressional investigations, and legislative... View Details
    Keywords: Brands and Branding; Policy; Risk Management; Government Legislation; Risk and Uncertainty; Goals and Objectives; Customers; Pharmaceutical Industry; Health Industry; United States
    Citation
    Find at Harvard
    Read Now
    Related
    Daemmrich, Arthur A. "Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation." Pharmacy in History 49, no. 2 (2007): 61–75.
    • January 2014
    • Case

    The Weather Company

    By: Rosabeth Moss Kanter
    New CEO David Kenny transformed The Weather Company in less than two years from a primary identity as a cable television channel to a multi-platform digital company innovating in the uses of weather data. He assesses progress and considers strategic choices and... View Details
    Keywords: Innovation; Strategy; Strategic Change; Change Management; Expansion; Weather; Growth and Development Strategy; Innovation and Invention; Technology Industry
    Citation
    Educators
    Purchase
    Related
    Kanter, Rosabeth Moss. "The Weather Company." Harvard Business School Case 314-083, January 2014.
    • 05 Jul 2023
    • What Do You Think?

    How Are Middle Managers Falling Down Most Often on Employee Inclusion?

    (DEI)—the holy trinity of organizational development at present. Team members with diverse backgrounds, especially in creative types of work, have been shown to deliver better ideas and bottom-line results than those in less diverse teams... View Details
    Keywords: by James Heskett
    • November 2006 (Revised February 2007)
    • Case

    Microsoft Xbox: Changing the Game?

    By: Andrei Hagiu
    In September 1999, the Microsoft Xbox team was wondering which strategic choices would give it the best chance against the upcoming Sony PlayStation 2. Initially called "Project Midway" within Microsoft, the console project was intended to counter the perceived threat... View Details
    Keywords: Customers; Recruitment; Leadership; Management Teams; Multi-Sided Platforms; Two-Sided Platforms; Production; Strategy; Competition; Expansion; Video Game Industry; Texas
    Citation
    Educators
    Purchase
    Related
    Hagiu, Andrei. "Microsoft Xbox: Changing the Game?" Harvard Business School Case 707-501, November 2006. (Revised February 2007.)
    • Program

    Senior Executive Leadership Program—India

    carefully designed to facilitate your growth. Your learning will take place on your own, in your small learning group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & View Details
    • Article

    Health Equity, Schooling Hesitancy, and the Social Determinants of Learning

    By: Meira Levinson, Alan C. Geller, Joseph G. Allen and John D. Macomber
    At least 62 million K-12 students in North America—disproportionately low-income children of color— have been physically out of school for over a year due to the COVID-19 pandemic. These children are at risk of significant academic, social, mental, and physical harm... View Details
    Keywords: COVID-19; Public Health; Air Quality; Social Determinants Of Health; Schooling Hesitancy; Vaccine Hesitancy; Racial Injustice; Inequity; Inequality; Health Pandemics; Education; Health Care and Treatment; Policy; Race; Equality and Inequality
    Citation
    Read Now
    Related
    Levinson, Meira, Alan C. Geller, Joseph G. Allen, and John D. Macomber. "Health Equity, Schooling Hesitancy, and the Social Determinants of Learning." Art. 100032. Lancet Regional Health – Americas 2 (October 2021).
    • 2024
    • Article

    Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway

    By: Mateo Aboy, Cristina Crespo and Ariel Stern
    Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between... View Details
    Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technology Adoption; Technological Innovation; Safety; Medical Devices and Supplies Industry; United States
    Citation
    Read Now
    Related
    Aboy, Mateo, Cristina Crespo, and Ariel Stern. "Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway." Art. 29. npj Digital Medicine 7 (2024).
    • 2024
    • Chapter

    The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives

    By: Ariel Dora Stern
    For those who follow health and technology news, it is difficult to go more than a few days without reading about a compelling new application of Artificial Intelligence (AI) to health care. AI has myriad applications in medicine and its adjacent industries, with... View Details
    Citation
    Related
    Stern, Ariel Dora. "The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives." Chap. 4 in The Economics of Artificial Intelligence: Health Care Challenges, edited by Ajay Agrawal, Joshua Gans, Avi Goldfarb, and Catherine E. Tucker, 107–138. Chicago and London: University of Chicago Press, 2024.
    • November 2020
    • Case

    Truebird—An AlleyCorp Venture

    By: Shikhar Ghosh and Shweta Bagai
    In December 2018, Kevin Ryan and Wendy Tsu faced an important decision – to finalize the CEO candidate for Truebird, an innovative, automated coffee café concept. Like many of AlleyCorp and Ryan’s companies, Truebird started with the observation of an unmet need – an... View Details
    Keywords: Startup; Hiring; Staffing; Recruiting; Business Startups; Finance; Leadership; Management Skills; Management Teams; Jobs and Positions; Job Interviews; Human Resources; Recruitment; Selection and Staffing; Technology Industry; Food and Beverage Industry; United States
    Citation
    Educators
    Purchase
    Related
    Ghosh, Shikhar, and Shweta Bagai. "Truebird—An AlleyCorp Venture." Harvard Business School Case 821-030, November 2020.
    • Program

    Creating Brand Value

    facilitate your growth. Your learning will take place on your own, in your living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We... View Details
    • November 2017
    • Case

    The 'Wonder Drug' That Killed Babies

    By: Joshua Lev Krieger, Tom Nicholas and Matthew Preble
    In the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children... View Details
    Keywords: Regulation; Business and Government Relations; Business and Community Relations; Business and Stakeholder Relations; Product Marketing; Corporate Social Responsibility and Impact; Business History; Health; Government Legislation; Corporate Accountability; Ethics; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Public Administration Industry; United States; United Kingdom; Australia; Germany; Europe
    Citation
    Educators
    Purchase
    Related
    Krieger, Joshua Lev, Tom Nicholas, and Matthew Preble. "The 'Wonder Drug' That Killed Babies." Harvard Business School Case 818-044, November 2017.
    • 29 Mar 2011
    • Working Paper Summaries

    Risky Trust: How Multi-entity Teams Develop Trust in a High Risk Endeavor

    Keywords: by Faaiza Rashid & Amy C. Edmondson
    • ←
    • 29
    • 30
    • …
    • 76
    • 77
    • →
    ǁ
    Campus Map
    Harvard Business School
    Soldiers Field
    Boston, MA 02163
    →Map & Directions
    →More Contact Information
    • Make a Gift
    • Site Map
    • Jobs
    • Harvard University
    • Trademarks
    • Policies
    • Accessibility
    • Digital Accessibility
    Copyright © President & Fellows of Harvard College.